FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR NEOADJUVANT/ADJUVANT METASTATIC UROTHELIAL CANCER

NEXT STORY
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Münster in Germany
PREV STORY
Ventilator Demand has Soared Amid the COVID-19 Pandemic: How are Manufacturers Meeting Demand? – ResearchAndMarkets.com
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member

author_avatar
NASDAQ Market News

Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients

author_avatar
NASDAQ Market News

HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration

TUCSON, Ariz., April 24, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a ...

author_avatar
NASDAQ Market News